Introduction {#s1}
============

*Allium* plants (Allieae), such as garlic, onion, and chives, have been cultivated as not only foodstuffs but also medicinal plants in the worldwide from ancient. For example, the extract of *Allium* plants, such as garlic, has shown anticancer, antidiabetic, and antibacterial effects. In addition, the National Cancer Institute in the United States had focused on *Allium* species as expecting cancer prevention (Theisen, [@B21]). *Allium* plants are well-known to have various cysteine sulfoxide derivatives such as alliin, methiin, and propiin (Rose et al., [@B20]). The type and contents of cysteine sulfoxides were also known to be different among *Allium* species (Fritsch and Keusgen, [@B9]). The cysteine sulfoxides change to thiosulfinates, such as allicin (Cavallito and Bailey, [@B5]; Cavallito et al., [@B6]), by the reaction with enzyme called alliinase (Ellmore and Feldberg, [@B8]) when the tissues of *Allium* plants are broken. Allicin has been reported to have several biological effects (Gebhardt et al., [@B13]; Briggs et al., [@B3]; Cañizares et al., [@B4]; Oommen et al., [@B19]; Arditti et al., [@B1]). However, unstable thiosulfinates including allicin are changed to organosulfur compounds, such as ajoene (Block et al., [@B2]), methyl 1-(methylthio)ethyl disulfane, and 5,7-diethyl-1,2,3,4,6-pentathiepane (Kuo et al., [@B15]). These compounds are also comparatively unstable and volatile. Although ajoene was known to have significantly anticancer effect, the application as medicines is difficult. On the other hand, several cyclic organosulfur compounds with anticancer effects isolated from the bulbs of the *Allium sativum* (garlic) have been reported by Nohara et al. ([@B18], [@B16], [@B17]). Thus, cyclic organosulfur compounds are important on the development of medicines including anticancer effect. On the basis of this background, we have isolated several comparatively stable organosulfur compounds from *Allium fistulosum* (green onion and welsh onion) (Fukaya et al., [@B12], [@B10]) and *Allium schoenoprasum* var. *foliosum* (Japanese chive) (Fukaya et al., [@B11]). In the course of our ongoing research program for discovery of bioactive organosulfur compounds, the constituents from the leaves of *Allium sativum* were examined. In this article, we discuss the isolation and the structure elucidation of cyclic organosulfur compounds, foliogarlic disulfanes A~1~ (**1**), A~2~ (**2**), and A~3~ (**3**) and foliogarlic trisulfane A~1~(**4**) and A~2~ (**5**), from the leaves of *A. sativum* and the biosynthetic pathways.

Results and Discussions {#s2}
=======================

The fresh leaves of *A. sativum* (15.0 kg) were mixed with water. Then, acetone was added into the mixture to be 80% acetone solution. The solution was concentrated after standing for 4 days (96 h) at room temperature. The acetone extract was portioned between ethyl acetate (EtOAc) and water. The organic fraction was evaporated *in vacuo* and obtained EtOAc fraction as syrup (41.98 g, 0.27% from the plant). The EtOAc fraction was also subjected with the normal and reversed-phase column chromatography and high-performance liquid chromatography (HPLC) to give foliogarlic disulfanes A~1~ (**1**, 0.00013%), A~2~ (**2**, 0.00021%), and A~3~ (**3**, 0.00009%) and foliogarlic trisulfanes A~1~ (**4**, 0.00015%) and A~2~ (**5**, 0.00008%) ([Figure 1](#F1){ref-type="fig"}).

![Structures of new compounds **1-5** from the leaves of *A. sativum*.](fchem-08-00282-g0001){#F1}

Foliogarlic disulfanes A~1~ (**1**) was obtained as yellow oil and showed positive optical rotation (+160.9). In the Electrospray Ionization MS (ESIMS) measurement of **1**, a pseudomolecular ion peak \[M + Na\]^+^ was observed at *m/z* 343.0282, and the molecular formula was determined as C~12~H~16~O~6~S~2~ on the basis of the High Resolution ESIMS (HRESIMS) peak and the ^13^C NMR data. The ^13^C NMR spectra of **1** showed signals corresponding to a secondary methyl group at δ~C~ 9.1 (6-CH~3~), a methine at δ~C~ 48.1 (C-6), a diastereotopic oxygen-bearing methylene at δ~C~ 74.98 (C-3); an oxygen-bearing methine at δ~C~ 75.03 (C-2); two methines neighboring the electron-withdrawing atom at δ~C~ 90.4 (C-3a) and δ~C~ 103.2 (C-7); an oxygen-bearing quaternary carbon at δ~C~ 79.6 (C-5a); a two-oxygen--bearing quaternary carbon at δ~C~ 119.1 (C-8a); and a lactone carbonyl carbon at δ~C~ 175.4 (C-5) ([Table 1](#T1){ref-type="table"}, [Figure 2](#F2){ref-type="fig"}, and [Supplementary Material](#SM1){ref-type="supplementary-material"}). The correlations of COSY double-quantum filter (DQF COSY) NMR spectroscopy were observed between 6-CH~3~, H-6, and H-7 and between H-2, H-3, and H-3a ([Figure 2](#F2){ref-type="fig"}). The heteronuclear multiple-bond correlation (HMBC) spectrum of **1** is shown in [Figure 2](#F2){ref-type="fig"}. Namely, the correlation of H-2 to C-8a, H-7 to C-5a and H-3a to C-5a indicates acetal structure, the correlation of H-3a to C-5 and C-5a indicates a lactone, and the correlations of H-6 to C-5a and C-7, H-7 to C-5 and 6-CH~3~, 6-CH~3~ to C-5a, C-6, and C-7 indicate a secondary methyl moiety. These evidences indicate that compound **1** had a tetrahydro-2*H*-difuro\[3,2-b:2′,3′-c\]furan-5(5a*H*)-one skeleton. In addition, 1-propenyl disulfane structure at the side chain was confirmed by High Resolution MS (HRMS) and NMR (Nuclear Magnetic Resonance) data. Next, the NOESY spectrum of **1** showed key correlations between H-3a and H-6; and H-6 and H-7 ([Figure 2](#F2){ref-type="fig"}). The results prove that the relative configurations among H-3, H-6, and H-7 were of the same orientation, respectively. Furthermore, the ^1^H and ^13^C NMR signals of **1** assigned to tetrahydro-2*H*-difuro\[3,2-b:2′,3′-c\]furan-5(5a*H*)-one skeleton were superimposable on those of known compound, kujounin A~3~, except for 1-propenyl disulfane moiety (Fukaya et al., [@B10]). All the evidences support that the chemical structure of **1** was (3*S*^\*^,3a*R*^\*^,5a*S*^\*^,6*R*^\*^,7*R*^\*^,8a*R*^\*^)-3,5a-dihydroxy-6-methyl-7-(allyldisulfanyl)tetrahydro-2*H*-difuro\[3,2-*b*:2′,3′-*c*\]furan-5(5a*H*)-one.

###### 

^1^H NMR and ^13^C NMR data of **1** and **2**.

  **Position**   **1**                 **2**   **2**                                                              
  -------------- --------------------- ------- --------------------------- ------- ------------------------------ -------
  2              4.05 (m)              75.03   4.00 (dd, *J* = 5.5, 7.5)   75.0    α 4.11 (dd, *J* = 4.8, 10.3)   74.2
                                               4.01 (dd, *J* = 5.5, 9.5)           β 4.23 (dd, *J* = 3.4, 10.3)   
  3              4.30 (m)              74.98   4.30 (m)                    75.5    4.44 (m)                       74.4
  3a             4.62 (d-like)         90.4    4.60 (d, *J* = 2.5)         90.4    4.64 (d, *J* = 1.3)            88.6
  5                                    175.4                               175.0                                  171.4
  5a                                   79.6                                82.3                                   81.6
  6              2.91 (m)              48.1    2.63 (m)                    49.8    2.75 (m)                       49.7
  7              5.55 (d, 7.0)         103.2   4.78 (d, *J* = 7.0)         94.5    5.00 (d, *J* = 3.5)            97.5
  8a                                   119.1                               117.0                                  117.0
  3′             3.45 (m)              43.5    3.47 (d, *J* = 7.5)         43.8    3.48 (m)                       42.7
  4′             5.88 (m)              134.6   5.86 (m)                    134.4   5.88 (m)                       133.0
  5′             5.09 (d like, 10.0)   118.9   5.12 (d-like, *J* = 9.5)    119.1   5.15 (d-like, *J* = 11.6)      120.0
                 5.19 (d like, 17.0)           5.18 (d-like, *J* = 16.0)           5.20 (d-like, *J* = 16.4)      
  6-CH~3~        1.18 (d, 7.0)         9.1     1.13 (d, *J* = 7.5)         12.6    1.21 (d, *J* = 7.6)            14.0

*^1^H NMR, ^13^C NMR (CD~3~OD, 500 MHz)*.

*^1^H NMR, ^13^C NMR (CDCl~3~, 600 NMR)*.

![Key-correlations of 2D NMR and NOESY of **1-3**.](fchem-08-00282-g0002){#F2}

Foliogarlic disulfanes A~2~ (**2**) and A~3~ (**3**) were isolated as yellow oil with positive specific rotations (**2**: $\left\lbrack \alpha \right\rbrack_{\text{D}}^{25}$ + 139.0° in MeOH) and negative specific rotations (**3**: $\left\lbrack \alpha \right\rbrack_{\text{D}}^{25}$ -- 213.6° in MeOH). In the ESIMS spectra of **2** and **3**, the same quasi-molecular ion peaks (**2** and **3**: \[M+Na\]^+^) were observed at *m*/*z* 343. The molecular formulas (**2** and **3**: C~12~H~16~O~6~S~2~) were determined on the basis of HRESIMS peaks at \[**2**: *m/z* 343.0277, **3**: *m/z* 343.0282 (calcd. 343.0281)\] and the ^13^C NMR data. The ^1^H and ^13^C NMR spectrum of **2** and **3** showed signals corresponding to a secondary methyl group, a methine, a diastereotopic oxygen-bearing methylene, and an oxygen-bearing methine ([Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}). On the basis of this evidence and detailed examination of DQF COSY and HMBC experiments, the planner structures of **2** and **3** were found to be the same as that of **1**. Next, the relative configurations of **2** and **3** were characterized by the detailed NOESY experiments. The NOESY spectrum of **2** showed key correlations between H-3a and 6-CH~3~; and H-7 and 6-CH~3~ ([Figure 2](#F2){ref-type="fig"}). The NOESY spectrum of **3** showed key correlations between H-3a and H-6; and H-7 and 6-CH~3~ ([Figure 2](#F2){ref-type="fig"}). In addition, the ^1^H and ^13^C NMR signals of **2** and **3** were superimposable on those of known compounds, kujounin A~1~ and A~2~, respectively, except for 1-propenyl disulfane structure (Fukaya et al., [@B12]). Consequently, the chemical structures of foliogarlic disulfanes A~2~ (**2**) and A~3~ (**3**) were determined as (3*S*^\*^,3a*R*^\*^,5a*S*^\*^,6*S*^\*^,7*R*^\*^,8a*R*^\*^)-3,5a-dihydroxy-6-methyl-7-(allyldisulfanyl)tetrahydro-2*H*-difuro\[3,2-*b*:2′,3′-*c*\]furan-5(5a*H*)-one and (3*S*^\*^,3a*R*^\*^,5a*S*^\*^,6*R*^\*^,7*S*^\*^,8a*R*^\*^)-3,5a-dihydroxy-6-methyl-7-(allyldisulfanyl)tetrahydro-2*H*-difuro\[3,2-*b*:2′,3′-*c*\]furan-5(5a*H*)-one, respectively.

###### 

^1^H NMR and ^13^C NMR data of **3**.

  **Position**   **3**                                                               
  -------------- ---------------------------- ------- ------------------------------ -------
  2              4.04 (dd, *J* = 4.5, 10.0)   75.9    α 4.11 (dd, *J* = 4.1, 10.3)   75.4
                 4.07 (dd, *J* = 3.0, 10.0)           β 4.27 (dd, *J* = 1.4, 10.3)   
  3              4.29 (m)                     74.7    4.48 (m)                       73.9
  3a             4.75 (s-like)                89.9    4.85 (s-like)                  87.5
  5                                           174.9                                  172.2
  5a                                          80.0                                   78.4
  6              2.69 (m)                     47.9    2.71 (m)                       46.5
  7              5.11 (d, *J* = 10.0)         96.3    5.16 (d, *J* = 9.6)            95.5
  8a                                          119.1                                  117.2
  3′             3.46 (d, *J* = 7.5)          44.1    3.44 (d, *J* = 7.6)            43.2
  4′             5.85 (m)                     134.3   5.85 (m)                       132.5
  5′             5.14 (d like, *J* = 10.0)    119.4   5.19 (d like, *J* = 10.3)      119.5
                 5.20 (d like, *J* = 16.5)            5.22 (d like, *J* = 15.8)      
  6-CH~3~        1.09 (d, *J* = 6.5)          8.4     1.19 (d, *J* = 6.8)            7.9

*^1^H NMR, ^13^C NMR (CD~3~OD, 500 MHz)*.

*^1^H NMR, ^13^C NMR (CDCl~3~, 600 NMR)*.

Foliogarlic trisulfanes A~1~ (**4**) and A~2~ (**5**) were isolated as yellow oil with positive specific rotations (**4**: $\left\lbrack \alpha \right\rbrack_{\text{D}}^{25}$ +124.6° in MeOH) and negative specific rotations (**5**: $\left\lbrack \alpha \right\rbrack_{\text{D}}^{25}$ −119.8° in MeOH). In the ESIMS spectra of **4** and **5**, the same quasi-molecular ion peaks (**4** and **5**: \[M+Na\]^+^) were observed at *m*/*z* 375. The molecular formulas (**4** and **5**: C~12~H~16~O~6~S~3~) were determined on the basis of HRESIMS peaks at \[**4**: *m/z* 374.9998, **3**: *m/z* 374.0003 (calcd. 374.0001)\], and the ^13^C NMR data. On the basis of the detailed analysis of the ^1^H and ^13^C NMR, 2D-NMR (DQF COSY, HMBC, NOESY) spectrum of **4** and **5**, the relative structures of tetrahydro-2*H*-difuro\[3,2-*b*:2′,3′-*c*\]furan-5(5a*H*)-one skeleton on **4** and **5** were found to be the same as those of **1** and **3**, respectively ([Tables 3](#T3){ref-type="table"}, [4](#T4){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}). Next, the ^1^H and ^13^C NMR spectrum at the side chain showed signals corresponding to an allyl group, as well as those of compounds **1**--**3**. The determination of the sulfur linkage was confirmed by the HRMS spectrum. Namely, the pseudomolecular formula was established as C~12~H~16~O~6~S~3~Na. Therefore, compounds **4** and **5** were found to have a trisulfane bridge. Finally, the relative configurations of **4** and **5** were characterized by the comparison of ^13^C NMR data with **1** and **3** and the NOESY experiments. The ^13^C NMR signals of **4** and **5** were superimposable on those of **1** and **3**. All the evidences supported that the chemical structures of **4** and **5** were (3*S*^\*^,3a*R*^\*^,5a*S*^\*^,6*R*^\*^,7*R*^\*^,8a*R*^\*^)-3,5a-dihydroxy-6-methyl-7-(allyltrisulfanyl)tetrahydro-2*H*-difuro\[3,2-*b*:2′,3′-*c*\]furan-5(5a*H*)-one and (3*S*^\*^,3a*R*^\*^,5a*S*^\*^,6*R*^\*^,7*S*^\*^,8a*R*^\*^)-3,5a-dihydroxy-6-methyl-7-(allyltrisulfanyl)tetrahydro-2*H*-difuro\[3,2-*b*:2′,3′-*c*\]furan-5(5a*H*)-one, respectively.

###### 

^1^H NMR and ^13^C NMR data of **4**.

  **Position**   **4**                                                           
  -------------- ---------------------------- ------- -------------------------- -------
  2              4.07 (m)                     75.7    4.28 (m)                   75.0
  3              4.26 (m)                     75.0    4.42 (m)                   73.9
  3a             4.66 (d, *J* = 1.5)          90.6    4.68 (s-like)              88.5
  5                                           175.1                              170.2
  5a                                          79.5                               78.0
  6              2.97 (m)                     48.0    2.83 (m)                   47.0
  7              5.68 (d, *J* = 7.0)          102.3   5.71 (d, *J* = 6.9)        99.5
  8a                                          119.1                              119.0
  3′             3.59 (dd, *J* = 6.5, 13.0)   42.3    3.49 (m)                   42.6
                 3.63 (dd, *J* = 7.5, 13.0)                                      
  4′             5.86 (m)                     134.3   5.86 (m)                   132.5
  5′             5.17 (d-like, *J* = 10.0)    119.5   5.16 (d-like, *J* = 9.6)   119.6
                 5.22 (d-like, *J* = 17.0)            5.21 (*J* = 16.5)          
  6-CH~3~        1.16 (d, *J* = 7.0)          9.2     1.28 (d, *J* = 6.9)        8.6

*^1^H NMR, ^13^C NMR (CD~3~OD, 500 MHz)*.

*^1^H NMR, ^13^C NMR (CDCl~3~, 600 NMR)*.

###### 

^1^H NMR and ^13^C NMR data of **5**.

  **Position**   **5**                       
  -------------- --------------------------- -------
  2              4.02 (m)                    75.6
  3              4.25 (m)                    75.1
  3a             4.71 (d, *J* = 1.5)         90.2
  5                                          175.0
  5a                                         80.1
  6              2.63 (m)                    48.2
  7              5.23 (d, *J* = 9.5)         96.6
  8a                                         118.8
  3′             3.56 (m)                    42.7
  4′             5.82 (m)                    134.0
  5′             5.15 (d like, *J* = 10.0)   119.9
                 5.21 (d like, *J* = 16.5)   
  6-CH~3~        1.11 (d, *J* = 6.5)         8.7

*^1^H NMR, ^13^C NMR (CD~3~OD, 500 MHz)*.

![Key-correlations of 2D NMR and NOESY of **4** and **5**.](fchem-08-00282-g0003){#F3}

The biological synthetic pathways for compounds **1**--**5** are presumed. At first, allicin is generated from alliin by alliinase when plant tissues of *A. sativum* are broken. Next, allicin is decomposed into intermediates (a), (b), and (c) by hydrolysis and is reconstructed to disulfane (d) and trisulfane (e) (Jacob, [@B14]). Finally, the structure of tetrahydro-2*H*-difuro\[3,2-*b*:2′,3′-*c*\]furan-5(5a*H*)-one skeleton is formed from semidehydroascorbate by cyclization and sulfane formation with the intermediates d and e. Consequently, compounds **1**--**5** were presumed to be obtained ([Figure 4](#F4){ref-type="fig"}).

![The biological synthetic pathway for compounds **1-5**.](fchem-08-00282-g0004){#F4}

Conclusion {#s3}
==========

Five new organosulfur compounds, foliogarlic disulfanes **1**--**3** and foliogarlic trisulfanes **4** and **5**, were isolated from the leaves of *A. sativum*. These compounds **1**--**5** have a tetrahydro-2*H*-difuro\[3,2-*b*:2′,3′-*c*\]furan-5(5a*H*)-one skeleton with methyl group at 6-position and 2-propenyl disulfane or 2-propenyl trisulfane group at 7-position. Particularly, foliogarlic trisulfanes **4** and **5** with a trisulfane moiety are a rare compound derived from medicinal plants. The biological effects of these cyclic organosulfur compounds should be studied further.

Experimental {#s4}
============

General
-------

The following instruments were used to obtain physical data: specific rotations, a Horiba (Kyoto, Japan) SEPA-300 digital polarimeter (*l* = 5 cm); IR spectra, JASCO (Tokyo, Japan) FT/IR-4600 Fourier Transform Infrared Spectrometer; ESIMS, Agilent Technologies (CA, US) Quadrupole LC/MS 6130; HRESIMS, SHIMADZU LCMS-IT-TOF; ^1^H NMR spectra, JEOL (Tokyo, Japan) JNM-LA 500 (500 MHz) spectrometer; ^13^C-NMR spectra, JEOL JNM-LA 500 (125 MHz) spectrometer; NOESY spectra, JNM-ECA 600 (600 MHz) spectrometer; HPLC, a Shimadzu (Kyoto, Japan) SPD-20AVP UV-VIS detector. YMC-triart C18 (250 × 4.6 mm i.d. and 250 × 10 mm i.d.) and YMC-triart PFP (250 × 4.6 mm i.d. and 250 × 10 mm i.d.) columns were used for analytical and preparative purposes. The following experimental materials were used for chromatography: normal-phase silica gel column chromatography, silica gel BW-200 (Fuji Silysia Chemical, Ltd. (Aichi, Japan, 150--350 mesh); reversed-phase silica gel column chromatography, Cosmosil 140C~18~-OPN \[Nacalai Tesque (Kyoto, Japan)\], TLC, precoated TLC plates with silica gel 60F~254~ \[Merck (NJ, US), 0.25 mm\] (ordinary phase), and silica gel RP-18 F~254S~ (Merck, 0.25 mm) (reversed phase); reversed-phase HPTLC, precoated TLC plates with silica gel RP-18 WF~254S~. Detection was achieved by spraying with 1% Ce (SO~4~) 2--10% aqueous H~2~SO~4~ followed by heating.

Plant Material
--------------

Fresh leaves of *A. sativum* cultivated in Kochi prefecture, Japan, were obtained as commercial products purchased from Japan Agricultural Cooperatives (JA) farmers\' market (Kochi, Japan) in April 2017. The plants were identified by the authors (H.M. and S.N.).

Extraction and Isolation
------------------------

The fresh leaves of *A. sativum* (15.2 kg) were chopped and mixed with water, and then acetone was added to the mixture to be 80% acetone solution. The mixture was soaked for 4 days (96 h) at room temperature. Evaporation of the filtrate under reduced pressure provided acetone extract (1,500.37 g, 9.87%). The extract was partitioned between EtOAc and H~2~O (1:1, vol/vol) to obtain EtOAc fraction (41.98 g, 0.27%) and aqueous phase. The EtOAc-soluble fraction (41.98 g) was subjected to normal phase silica gel column chromatography \[1,260 g, CHCl~3~-MeOH (1:0 → 100:1 → 50:1 → 30:1 → 10:1 → 0:1, vol/vol)\] to give nine fractions {Fr.1 (1,471.6 mg), Fr.2 (715.5 mg), Fr.3 (7,193.2 mg), Fr.4 (8,339.2 mg), Fr.5 (4,085.8 mg), Fr.6 (1,334.9 mg), Fr.7 (4,367.0 mg), Fr.8 (617.7 mg), Fr.9 (5,841.2 mg)}. r. 5 (4,085.8 mg) was further separated by reversed-phase silica gel column chromatography \[200 g, MeOH-H~2~O (2:8 → 4:6 → 6:4 → 8:2 → 1:0, vol/vol)\] to give 13 fractions {Fr.5-1 (52.3 mg), Fr.5-2 (21.0 mg), Fr.5-3 (31.0 mg), Fr.5-4 (19.1 mg), Fr.5-5 (84.4 mg), Fr.5-6 (281.7 mg), Fr.5-7 (43.5 mg), Fr.5-8 (26.3 mg), Fr.5-9 (67.9 mg), Fr.5-10 (482.9 mg), Fr.5-11 (2,637.7 mg), Fr.5-12 (178.7 mg), Fr.5-13 (16.9 mg)}. Fr.5-5 (84.4 mg) was purified by HPLC {mobile phase: MeOH-H~2~O (35:65, vol/vol) \[YMC-triart PFP (250 × 10 mm i.d.)\]} to give **1** (6.0 mg) and **2** (16.3 mg). Fr.5-6 (281.7 mg) was purified by HPLC {mobile phase: MeOH-H~2~O (50:50, vol/vol) \[YMC-triart C18 (250 × 10 mm i.d.)\]} to give **1** (14.6 mg), **2** (16.0 mg), **4** (24.2 mg), and **5** (12.3 mg). Fr.5-6-5 (37.1 mg) was purified by HPLC {mobile phase: MeOH-H~2~O (45:55, vol/vol) \[YMC-triart C18 (250 × 10 mm i.d.)\]} to give **3** (14.7 mg) and **4** (4.5 mg).

Foliogarlic Disulfane A~1~ (1)
------------------------------

Yellow oil; $\left\lbrack \alpha \right\rbrack_{\text{D}}^{25}$ +160.9 (MeOH); HRESIMS: calcd for C~12~H~16~O~6~S~2~Na (M+Na)^+^: 343.0281, found: 343.0282; IR(ATR): 3,400, 2,975, 1,782 cm^−1^; ^1^H NMR (CD~3~OD), ^13^C NMR (CD~3~OD, 500 MHz): given in [Table 1](#T1){ref-type="table"}.

Foliogarlic Disulfane A~2~ (2)
------------------------------

Yellow oil; $\left\lbrack \alpha \right\rbrack_{\text{D}}^{25}$ +139.0 (MeOH); HRESIMS: calcd for C~12~H~16~O~6~S~2~Na (M+Na)^+^: 343.0281, found: 343.0277; IR(ATR): 3,400, 2,970, 1,785 cm^−1^; ^1^H NMR (CD~3~OD, CDCl~3~), ^13^C NMR (CD~3~OD, CDCl~3~): given in [Table 1](#T1){ref-type="table"}.

Foliogarlic Disulfane A~3~ (3)
------------------------------

Yellow oil; $\left\lbrack \alpha \right\rbrack_{\text{D}}^{25} -$213.6 (MeOH); HRESIMS: calcd for C~12~H~16~O~6~S~2~Na (M+Na)^+^: 343.0281, found: 343.0282; IR(ATR): 3,400, 2,981, 1,785 cm^−1^; ^1^H NMR (CD~3~OD, CDCl~3~), ^13^C NMR (CD~3~OD, CDCl~3~): given in [Table 2](#T2){ref-type="table"}.

Foliogarlic Trisulfane A~1~ (4)
-------------------------------

Yellow oil; $\left\lbrack \alpha \right\rbrack_{\text{D}}^{25}$ +124.6 (MeOH); HRESIMS: calcd for C~12~H~16~O~6~S~3~Na (M+Na)^+^: 375.0001, found: 374.9998; IR(ATR): 3,400, 2,975, 1,780 cm^−1^; ^1^H NMR (CD~3~OD, CDCl~3~), ^13^C NMR (CD~3~OD, CDCl~3~): given in [Table 3](#T3){ref-type="table"}.

Foliogarlic Trisulfane A~2~ (5)
-------------------------------

Yellow oil; $\left\lbrack \alpha \right\rbrack_{\text{D}}^{25} -$119.8 (MeOH); HRESIMS: calcd for C~12~H~16~O~6~S~3~Na (M+Na)^+^: 375.0001, found: 375.0003; IR(ATR): 3,400, 2,931, 1,789 cm^−1^; ^1^H NMR (CD~3~OD), ^13^C NMR (CD~3~OD): given in [Table 4](#T4){ref-type="table"}.
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